Progress in preclinical safety evaluation of cell products derived from human induced pluripotent stem cells
李倩倩, 郝晓芳, 黄瑛, 耿兴超
Chinese Medicinal Biotechnology . 2024, (6): 521 -525 .  DOI: 10.3969/j.issn.1673-713X.2024.06.005